MEDCu Technologies News
2 articles
growth-positive
Innovative Israeli 'copper' dressing helps cure diabetic wounds
Israeli company MedCu Technologies has developed a wound dressing containing copper oxide that has been found to significantly stimulate the healing of diabetic wounds. The dressing has received clearance from major international regulatory bodies, including the FDA, for use in acute and chronic wounds. The copper oxide in the dressing has antimicrobial properties and helps protect the wound from infections. It also plays a role in the production of new blood capillaries, which is essential for wound healing. A small clinical trial involving 13 diabetic patients showed an average reduction of 65% in wound size after treatment with the MedCu wound dressing. The company plans to conduct a larger, randomized study to further demonstrate the efficacy of their dressings.
Customers
growth-positive
Medcu Antibacterial Wound Dressings With Copper-oxide (medcu Abwds) 510(k) FDA Premarket Notification K180643 MedCu Technologies, Ltd.
The article discusses the classification of MedCu Antibacterial Wound Dressings With Copper-Oxide (MedCu ABWDs) by the FDA. The device, developed by MedCu Technologies, Ltd., has been deemed substantially equivalent (SESE) by the FDA. This classification is growth-positive for the company. The key theme of the article is the regulatory approval of the MedCu ABWDs. The key issues discussed in the article are related to customers, as the FDA classification allows the company to market and sell the wound dressings. The article does not mention any specific partners or customers. The date of the event described in the article is November 23, 2018. The confidence level of the answer is 8.
Customers
